Summary
Overview
Work History
Education
Skills
Languages
Presentations
Industrial Experience
Scholastic Honors
Research Publications
Personal Information
Patents
Instrumentation Skills
References
Extracurricular Activities
Projects
Book Reading
Timeline
Generic

Nilesh Saindane

NASHIK

Summary

Meticulous and well-trained formulation development scientist bringing top-notch expertise in formulation development and contributing to successful product development.

Detail-oriented team player with strong organizational skills. Ability to handle multiple projects simultaneously with a high degree of accuracy.

Overview

18
18
years of professional experience

Work History

DGM, FORMULATION DEVELOPMENT

MEDREICH
12.2024 - Current
  • Formulation Development Team Leadership
  • Global Product Development (UK, Europe, Australia, CIS)
  • Oral Solid Dosage Forms (IR, ER, Abuse-Deterrent, ODT, Sachets)
  • Liquid Formulations (Oral Liquids, Suspensions)

FORMULATION DEVELOPMENT MANAGER

ASPIRE PHARMA
01.2020 - 12.2024

Formulation Development Expertise

  • Extensive experience in the development of oral solids (IR, SR/ER), injections, semisolids (creams, lotions, gels), and liquids (oral liquids, suspensions) for US, Europe, and Canada markets.
  • Skilled in independent and collaborative team environments, with a proven ability to thrive in fast-paced settings.
  • Proficient in monitoring and recommending formulation development activities with CDMOsand CMOs for medicinal products and medical devices.
  • Strong sense of personal responsibility and self-motivation, with a focus on delivering high-quality results.

Key Contributions

  • Finalized and recommended formulation development strategies to align with project goals and regulatory requirements.
  • Developed and evaluated prototype formulations, optimized formulas and processes using QbDand DOE, and conducted stability assessments.
  • Developed product specifications based on ICH guidelines, pharmacopoeia monographs, and product requirements.
  • Led technology transfer, problem-solving, and modification efforts for seamless scale-up and commercialization.
  • Coordinated and communicated effectively with internal cross-functional teams, CDMOs, and CMOs to ensure project alignment and timely delivery.
  • Provided regulatory support for dossier filings and addressed regulatory queries to ensure compliance.
  • Drove continuous improvement initiatives and demonstrated leadership in resolving challenges during site transfers and troubleshooting of commercial products.

GROUP LEADER

TORRENT RESEARCH CENTER
12.2017 - 01.2020
  • Osmotic Drug delivery System and Modified Release tablet formulations, Immediate Release Formulation, Suspension formulation, IVIVC (GASTROPLUS, Pheonix), QBD, DOE (MINI TAB), PAT tools, Worked for domestic, Europe and US market.

RESEARCH SCIENTIST R5

WOCKHARDT RESEARCH CENTER
07.2013 - 01.2017
  • Successfully developed IR, SR (osmotic drug delivery systems and modified-release tablet formulations) for US and European markets, demonstrating expertise in advanced drug delivery technologies.
  • Received special recognition from Wockhardt USA for the successful development of a complex formulation, showcasing innovation and problem-solving skills.
  • Streamlined research and development processes to meet tight deadlines for multiple projects, improving efficiency and time-to-market.
  • Developed and evaluated prototype formulations, optimized formulas and processes using QbDand DOE, and conducted stability assessments.
  • Developed product specifications based on ICH guidelines, pharmacopoeia monographs, and product requirements.
  • Led technology transfer, problem-solving, and modification efforts for seamless scale-up and commercialization.
  • Provided regulatory support for dossier filings and addressed regulatory queries to ensure compliance.
  • Drove continuous improvement initiatives and demonstrated leadership in resolving challenges during site transfers and troubleshooting of commercial products.

TEAM LEADER

KEMWELL BIOPHARMA
02.2012 - 07.2013
  • IR, SR and MR tablet formulations, Liquid and Suspension formulation for Europe and US market.

FORMULATION SCIENTIST

RUBICON RESEARH
08.2007 - 12.2007
  • Development of Immediate Release and Extended Release Product, ODT, Sublingual Product, NDDS Formulation, Osmotic Drug Delivery System (Push Pull and Elementary system), GastroRetentive DDS, Melt Granulation Formulation, Liquid and Suspension Formulation.

Education

Ph.D. (Tech) in Pharmaceutics -

Institute of Chemical Technology
Mumbai, Maharashtra
01.2012

Master of Pharmacy in Pharmaceutics -

Bharati Vidyapeeth's College of Pharmacy
Navi Mumbai, Maharashtra
01.2007

Bachelor of Pharmacy -

N.D.M.V. P's College of Pharmacy
Nashik, Maharashtra
01.2005

Diploma in Pharmacy -

Smt S.S. Patil Institute of Pharmacy
Jalgoan, Maharashtra
01.2002

Secondary education -

Madhyamik Vidyalay
Nashik, Maharashtra
01.2000

Skills

  • Specialized in Oral Solid Products (Immediate Release and Extended Release), Oral Liquid, Suspension, Semisolids, and Complex Generics
  • Particularly skilled in the development of Osmotic Drug Delivery Systems
  • Extensive project experience spanning the US, Europe, Canada, CIS, and Domestic Markets
  • Proven track record in developing generic, novel products, 505(b)2, and complex generics
  • Proficient in Quality by Design (QBD), Design of Experiments (DOE), Process Analytical Technology (PAT) tools, and In Vitro-In Vivo Correlation (IVIVC) tools

Languages

English
Hindi
Marathi

Presentations

  • Presented poster entitled "Counterfeit pharmaceuticals: Current status and prevention strategies" at 58th IPC, Mumbai, December, 2006
  • Presented poster entitled "Evaluation of effect of molecular weight an degree of deacetylation of chitosan on its mucoadhesive property" at The Second Indo-Canadian Satellite Symposium, Ooty, February 2007
  • Presented poster entitled "Rational use of anti-obesity drugs" at Bharati Vidyapeeths College of Pharmacy, Belapur, November 2006
  • Presented poster entitled "Synthesis of water soluble β-cyclodextrin polymers and to explore their application in enhancing solubility of water insoluble drug" at 60th IPC, New Delhi, December 2008
  • Presented poster entitled "Synthesis and characterization of amphiphilic star copolymer of betacyclodextrin and polypropylene oxide and their application as nanocarriers" at First European Cyclodextrin Conference at Aalborg, Denmark, October 2009
  • Presented poster entitled "Controlled release formulation of Glipizide based on Interpolymer complexation of Carbopol-Hydroxypropyl methyl Cellulose" at 62th IPC, Manipal, December 2010

Industrial Experience

Leadership in Formulation Development

  • Spearheaded the development of diverse pharmaceutical formulations, including immediate release (IR), extended release (ER), orally disintegrating tablets (ODT), sublingual products, and novel drug delivery systems (NDDS).
  • Pioneered advanced drug delivery technologies such as osmotic drug delivery systems (push-pull and elementary systems), gastroretentive drug delivery systems (GRDDS), and melt granulation formulations.
  • Led the development of solid oral products (IR, ER, ODT), suspensions, liquids, gels, eye drops, eye gels, and injection formulations, ensuring alignment with global regulatory standards.
  • Directed the preparation of development proposals, technical reports, and protocols, ensuring clarity and compliance with project objectives.
  • Conducted comprehensive literature and patent surveys to define innovative product development strategies and maintain competitive advantage.

Strategic and Technical Leadership

  • Oversaw preformulation studies, including reference product evaluation and compatibility studies, to establish a strong foundation for formulation development.
  • Championed formulation development, technology transfer, and scale-up activities, ensuring seamless transition from lab to commercial production.
  • Evaluated and interpreted bioequivalence (BE) data and analytical data to guide formulation optimization and decision-making.
  • Compiled and analyzed stability data to ensure product quality and compliance with ICH guidelines.
  • Developed and reviewed scientific protocols, PDRs, BMRs, MFRs, product specifications, validation protocols, reports, and departmental SOPs to maintain operational excellence.
  • Resolved technical challenges during product development, demonstrating strong problem-solving skills and ensuring project timelines were met.

Cross-Functional Collaboration and Innovation

  • Collaborated with cross-functional teams, including R&D, quality assurance, regulatory affairs, and manufacturing, to drive successful product development and commercialization.
  • Fostered a culture of continuous improvement by implementing best practices and innovative approaches in formulation development.
  • Mentored and guided team members, enhancing their technical expertise and ensuring high-performance outcomes.

Scholastic Honors

  • Secured All India Rank 63 and 99.44 percentile in Graduate Aptitude Test in Engineering (GATE-2005), conducted by Indian Institute of Technology Bombay, Mumbai (IIT).
  • Secured Rank 7 in Ph.D. Entrance examination conducted by ICT, Mumbai
  • Awarded Junior Research Fellowship by All India Council for Technical Education for the period of two years during Master's degree (2005-2007)
  • Awarded Senior Research Fellowship by University Grants Commission (UGC) for the period of four years during Ph.D. (Tech) degree (2008-2011).
  • Awarded International Travel Grant by Department of Science and Technology (DST) for presentation entitled "Synthesis and Characterization of Amphiphilic Star Copolymer of Betacyclodextrin and Polypropylene Oxide and Their Application as Nanocarriers at European Cyclodextrin Conference 2009, Aalborg, Denmark

Research Publications

  • Accepted Paper (Feb 2012), Osmotic pellet system comprising of osmotic core and in-process amorphized drug in polymer-surfactant layer for controlled delivery of poorly water-soluble drug, Journal of Pharmaceutical Sciences (Impact Factor 3.2).
  • Accepted Paper, Mucoadhesive bilayered buccal patches for administration of sumatriptan succinate, AAPS PharmSciTech, Vol. 9, No. 3, September 2008. (Impact Factor 1.4, Citations 31).
  • Accepted Paper, Nasal permeation enhancement of Sumatriptan through nasal mucosa, Indian Journal Pharmaceutical Sci., 2007, 69(5) 729-731 (Impact Factor 0.455, Citation 2).
  • Accepted Paper, Synthesis and Characterization of Amphiphilic Star Copolymer of Betacyclodextrin and Polypropylene Oxide and Their Application as Nanocarriers, Journal of Inclusion Phenomena and Macrocyclic Chemistry, Vol 69, Number 3-4, 383-392. (Impact Factor 1.2, Citation 1).
  • Accepted Paper, Inclusion complexation of weakly acidic NSAID with Beta-Cyclodextrin: selection of arginine, an amino acid, as a novel ternary component, Journal of Inclusion Phenomena and Macrocyclic Chemistry, Vol 69, Number 3-4, 453-460. (Impact Factor 1.2 Citations 4).
  • Accepted Paper, Nanosuspension Based In-Situ Gelling Nasal Spray of Carvedilol: Development, in-vitro and in-vivo characterization December 2012, AAPS PharmSciTech(Impact Factor 1.4)
  • Communicated Paper, Characterization of interpolymer complex of hydroxypropyl methyl cellulose and Carbopol for controlled drug release application, Journal of biomedical materials research part A (Impact Factor 3.1)

Personal Information

  • Gender: Male
  • Marital Status: Married
  • Date of Birth: 04/09/82
  • Nationality: Indian

Patents

  • Indian Patent Approved on "Multiparticulate controlled porosity osmotic system", complete specification, Application no. 2677/MUM/2011
  • Indian Patent Filed, "Pharmaceutical nasal spray composition for delivery of drugs", provisional application, Application no.2676/MUM/2011, Under Evaluation

Instrumentation Skills

  • Jasco High performance liquid chromatography (HPLC)
  • Waters High performance liquid chromatography (HPLC)
  • Differential Scanning Calorimety (Perkin Elmer, Pyris 6)
  • Particle Size Analyzer: Beckman Coulter and Malvern.
  • High speed Centrifuges and Rota-evaporator
  • 10 and 16 station rotary tablet press, Rimek Minipress-I and Cadmach, India.
  • Dissolution tester and Disintegration, Electrolab
  • Fluidized Bed Coater
  • Rapid Mixer Granulator
  • Convention Pan Coating and Autocoater

References

Prof P.R. Vavia, Professor of Pharamceutics, Institute of Chemical Technology, Matunga, Mumbai, Maharashtra, 400 019, +919867841777 Prof (Mrs) Supriya Shidhaye, Professor of Pharamceutics, Bharati Vidyapeeths College of Pharmacy, Navi Mumbai, Maharashtra, +919920585547

Extracurricular Activities

Actively involved in the design of website www.scientificipca.org for online submission of paper (first time in India) at 60th Indian Pharmaceutical Conference, New Delhi, also handled online submission of abstract and its evaluation Preparation of abstract book for 60th IPC 2008 and 61st IPC 2009

Projects

Formulation development and evaluation of Modified drug delivery system Formulation and evaluation of buccal drug delivery system

Book Reading

Passionate about reading scientific non-fiction books.

Timeline

DGM, FORMULATION DEVELOPMENT

MEDREICH
12.2024 - Current

FORMULATION DEVELOPMENT MANAGER

ASPIRE PHARMA
01.2020 - 12.2024

GROUP LEADER

TORRENT RESEARCH CENTER
12.2017 - 01.2020

RESEARCH SCIENTIST R5

WOCKHARDT RESEARCH CENTER
07.2013 - 01.2017

TEAM LEADER

KEMWELL BIOPHARMA
02.2012 - 07.2013

FORMULATION SCIENTIST

RUBICON RESEARH
08.2007 - 12.2007

Master of Pharmacy in Pharmaceutics -

Bharati Vidyapeeth's College of Pharmacy

Bachelor of Pharmacy -

N.D.M.V. P's College of Pharmacy

Diploma in Pharmacy -

Smt S.S. Patil Institute of Pharmacy

Secondary education -

Madhyamik Vidyalay

Ph.D. (Tech) in Pharmaceutics -

Institute of Chemical Technology
Nilesh Saindane